Overview

Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP

Status:
COMPLETED
Trial end date:
2023-12-15
Target enrollment:
Participant gender:
Summary
The aim of this randomized controlled trial was to explore the clinical efficacy and safety of HXTL in the treatment of NSLBP based on TCM principles and to compare the clinical outcomes of different syndromes of NSLBP with celecoxib.In this study, 80 patients with NSLBP were recruited and randomly grouped to use TCM compound and celeoxib respectively for intervention. The pain status and lumbar function use scale of patients were scored before intervention, 1 week, 2 weeks and 3 weeks after intervention, and the adverse reactions of patients after medication were recorded, and the clinical efficacy of the two groups of patients was compared finally.
Phase:
PHASE4
Details
Lead Sponsor:
Zhejiang Provincial Tongde Hospital
Treatments:
Celecoxib